A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andreas Moraitis, MD
Corcept Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
64 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 47
Vienna, Austria
- Site 27
Sofia, Bulgaria
- Site 70
Halifax, Nova Scotia, Canada
- Site 58
Montreal, Canada
- Site 54
München, Germany
- Site 49
Würzburg, Germany
- Site 30
Jerusalem, Israel
- Site 29
Kfar Saba, Israel
- Site 28
Petah Tikva, Israel
- Site 69
Tel Aviv, Israel
- Site 43
Ancona, Italy
- Site 15
Messina, Italy
- Site 26
Milan, Italy
- Site 12
Naples, Italy
- Site 38
Orbassano, Italy
- Site 67
Padova, Italy
- Site 16
Roma, Italy
- Site 40
Roma, Italy
- Site 34
Rotterdam, Netherlands
- Site 77
Bialystok, Poland
- Site 37
Chrzanów, Poland
- Site 59
Krakow, Poland
- Site 33
Lublin, Poland
- Site 63
Bucharest, Romania
- Site 64
Bucharest, Romania
- Site 66
Bucharest, Romania
- Site 73
Iași, Romania
- Site 75
Alicante, Spain
- Site 25
Girona, Spain
- Site 24
Madrid, Spain
- Site 22
Málaga, Spain
- Site 23
Seville, Spain
- Site 21
Phoenix, Arizona, United States
- Site 36
Los Angeles, California, United States
- Site 68
Torrance, California, United States
- Site 10
Miami, Florida, United States
- Site 14
Atlanta, Georgia, United States
- Site 41
Chicago, Illinois, United States
- Site 7
Indianapolis, Indiana, United States
- Site 2
Metairie, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2018
- Primary completion
- 8 Apr 2024
- Completion
- 15 Apr 2024
- Last update posted
- 16 Jul 2025
- Registered enrollment
- 152
- Registry id
- NCT03697109
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.